Patrick Frey

Patrick Frey is a highly experienced professional in the field of regulatory policy and drug evaluation, currently serving as Senior Director of Regulatory Policy at Neurocrine Biosciences since February 2024. Previously, Patrick held the role of Director and US Lead for Global Regulatory and R&D Policy at Amgen from September 2018 to February 2024. Patrick's extensive background includes significant positions at the U.S. Food and Drug Administration, where responsibilities included Chief of Staff for the Office of New Drugs and Senior Advisor to the Director. Prior roles also include positions at the Executive Office of the President and Merck & Co., Inc., along with early experience as a Chemist at The Valspar Corporation. Patrick Frey earned a Master of Public Policy from the University of Michigan and a Bachelor of Science in Chemistry from the University of Pittsburgh.